Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-06-13 Sale |
2023-06-15 7:25 pm |
BeiGene Ltd. | BGNE | HHLR ADVISORS LTD. HILLHOUSE INVESTMENT MANAGEMENT LTD. 10% Owner |
1,198,128 | $188.88 | $226,306,339 | 142,888,241 (Indirect) |
View |
| 2023-06-08 Sale |
2023-06-12 9:57 pm |
BeiGene Ltd. | BGNE | HHLR ADVISORS LTD. HILLHOUSE INVESTMENT MANAGEMENT LTD. 10% Owner |
2,956,689 | $201.98 | $597,183,858 | 144,086,369 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-06-15 Option Award |
2023-06-20 6:55 pm |
N/A 2033-06-14 |
BeiGene Ltd. | BGNE | Lee Chan Henry SVP, General Counsel |
314,535 | $0 | 430,547 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-20 6:53 pm |
N/A 2033-06-14 |
BeiGene Ltd. | BGNE | Wang Lai Global Head of R&D |
640,861 | $0 | 565,422 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-20 6:51 pm |
N/A 2033-06-14 |
BeiGene Ltd. | BGNE | Wang Julia Aijun Chief Financial Officer |
516,828 | $0 | 409,058 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-20 6:49 pm |
N/A 2033-06-14 |
BeiGene Ltd. | BGNE | Wu Xiaobin President, COO & GM China |
961,298 | $0 | 777,216 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-20 6:47 pm |
N/A 2033-06-14 |
BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd |
413,465 | $0 | 11,217,539 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-20 6:46 pm |
N/A 2033-06-14 |
BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer |
1,705,548 | $0 | 50,162,224 (Direct) |
View |
Ownership |
2023-06-20 6:37 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Lee Chan Henry SVP, General Counsel |
0 | $0 | 304,941 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-20 5:34 pm |
N/A 2033-06-14 |
BeiGene Ltd. | BGNE | BAKER BROS. ADVISORS LP 667 L.P. BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP Director 10% Owner |
133,744 | $0 | 11,891,052 (Indirect) |
View |
| 2023-06-15 Option Award |
2023-06-20 4:30 pm |
N/A 2033-06-14 |
BeiGene Ltd. | BGNE | Yi Qingqing Director |
39,897 | $0 | 56,589 (Direct) |
View |
| 2023-03-16 Gift |
2023-03-20 5:37 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd |
67,444 | $0 | 10,804,074 (Direct) |
View |
| 2023-03-08 Exercise |
2023-03-10 6:48 pm |
N/A 2023-04-03 |
BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd |
879,255 | $0 | 10,871,530 (Direct) |
View |
| 2023-03-08 Exercise |
2023-03-10 6:48 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd |
67,635 | $0.13 | 10,871,530 (Direct) |
View |
| 2022-11-28 Gift |
2022-11-30 5:00 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd |
52,000 | $0 | 11,040,687 (Direct) |
View |
| 2022-09-06 Gift |
2022-09-08 4:57 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd |
33,410 | $0 | 11,118,518 (Direct) |
View |
| 2022-08-22 Other |
2022-08-24 4:15 pm |
N/A N/A |
BeiGene Ltd. | BGNE | Yi Qingqing Director |
7,800 | $0 | 24,492 (Direct) |
View |
| 2022-08-22 Other |
2022-08-24 4:15 pm |
N/A N/A |
BeiGene Ltd. | BGNE | HHLR ADVISORS LTD. HILLHOUSE INVESTMENT MANAGEMENT LTD. 10% Owner |
7,800 | $0 | 147,050,858 (Indirect) |
View |
| 2022-06-22 Option Award |
2022-06-24 5:40 pm |
N/A 2032-06-21 |
BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer |
2,221,687 | $0 | 51,773,418 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 5:40 pm |
N/A 2032-06-21 |
BeiGene Ltd. | BGNE | Wang Lai Global Head of R&D |
833,131 | $0 | 2,276,053 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 5:40 pm |
N/A 2032-06-21 |
BeiGene Ltd. | BGNE | Wang Julia Aijun Chief Financial Officer |
694,265 | $0 | 835,471 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 5:39 pm |
N/A 2032-06-21 |
BeiGene Ltd. | BGNE | Wu Xiaobin President, COO & GM China |
1,249,690 | $0 | 2,066,046 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 5:39 pm |
N/A 2032-06-21 |
BeiGene Ltd. | BGNE | Dugan Margaret Director |
51,337 | $0 | 51,337 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 5:39 pm |
N/A 2032-06-21 |
BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd |
555,412 | $0 | 11,832,621 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 5:38 pm |
N/A 2032-06-21 |
BeiGene Ltd. | BGNE | HOOPER ANTHONY C Director |
51,337 | $0 | 59,137 (Direct) |
View |